Projects per year
Personal profile
Research interests
Dr. Xuemei Huang came to Penn State College of Medicine/Penn State College of Medicine in 2008.
Her research focuses on multidisciplinary approaches to understanding both etiology and neural mechanisms of neurodegenerative diseases and the mechanisms by which drugs work. Dr. Huang has been a consultant to the National Institutes of Environmental Health Sciences, and is a frequent grant reviewer for the National Institutes of Health, which has funded her research since 2003.
She is the author of more than 160 peer-reviewed research papers, as well as many chapters and research letters, and holds one patent.
She is the founding director of Penn State College of Medicine's Translational Brain Research Center. The center was started in 2017 to pursue and encourage bidirectional translational projects focused on brain neurodegeneration related to disease and aging.
Clinical interests
Dr. Xuemei Huang is chief of the Division of Movement Disorders in the Department of Neurology. Her clinical interests include:
- Parkinson’s disease (PD) in all stages, especially patients in the advanced to end stages of PD
- Progressive supranuclear palsy (PSP)
- Multiple system atrophy (MSA)
- Other atypical diseases that present like PD
- Botox to treat drooling and dystonia
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Movement Disorders and Clinical Research, Fellowship, Emory University
2000 → 2002
Neurology, Residency, University of North Carolina at Chapel Hill
1998 → 2000
Internship, University of Washington
1996 → 1997
Clinical Pharmacology and Toxicology, Fellowship, University of Colorado
1994 → 1996
Pharmacology, PhD, Purdue University
1989 → 1994
MD, Beijing Medical University
1981 → 1987
Fingerprint
Dive into the research topics where Xuemei Huang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance
Huang, X. & Kanthasamy, A. G.
National Institute of Neurological Disorders and Stroke
6/1/19 → 5/31/24
Project: Research project
-
Optimization and Statistical Procedures for Big Data and Applications
Li, R., Fang, X. X., Yao, T. & Huang, X.
10/1/16 → 6/30/23
Project: Research project
-
Indices of Motor Synergies as Early Biomarkers of Parkinson's Disease
National Institute of Neurological Disorders and Stroke
9/30/16 → 8/31/19
Project: Research project
-
Multimodal MRI markers of nigrostriatal pathology in Parkinson's disease
National Institute of Neurological Disorders and Stroke
9/30/12 → 8/31/15
Project: Research project
-
Manganese-related neurotoxicity in asymptomatic welders
National Institute of Environmental Health Sciences
8/16/11 → 4/30/13
Project: Research project
-
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x)
PASSPORT Study Group, Nov 2023, In: Nature Medicine. 29, 11, p. 2955-2956 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease
Lewis, M. M., Van Scoy, L. J., De Jesus, S., Hakun, J. G., Eslinger, P. J., Fernandez-Mendoza, J., Kong, L., Yang, Y., Snyder, B. L., Loktionova, N., Duvvuri, S., Gray, D. L., Huang, X. & Mailman, R. B., May 2023, In: Biomolecules. 13, 5, 829.Research output: Contribution to journal › Article › peer-review
Open Access -
Frontostriatal and limbic contributions to cognitive decline in Parkinson's disease
Brown, G., Hakun, J., Lewis, M. M., De Jesus, S., Du, G., Eslinger, P. J., Kong, L. & Huang, X., Jan 1 2023, In: Journal of Neuroimaging. 33, 1, p. 121-133 13 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Higher hippocampal diffusivity values in welders are associated with greater R2* in the red nucleus and lower psychomotor performance
Lee, E. Y., Kim, J., Prado-Rico, J. M., Du, G., Lewis, M. M., Kong, L., Kim, B. G., Hong, Y. S., Yanosky, J. D., Mailman, R. B. & Huang, X., May 2023, In: NeuroToxicology. 96, p. 53-68 16 p.Research output: Contribution to journal › Article › peer-review
-
Multi-muscle synergies in preparation for gait initiation in Parkinson's disease
Falaki, A., Cuadra, C., Lewis, M. M., Prado-Rico, J. M., Huang, X. & Latash, M. L., Oct 2023, In: Clinical Neurophysiology. 154, p. 12-24 13 p.Research output: Contribution to journal › Article › peer-review
Prizes
-
-
Scholarship in Education Award
Acharya, Vinita (Recipient), Foy, Andrew (Recipient), Vrana, Kent (Recipient), Huang, Xuemei (Recipient), Chetlen, Alison (Recipient), Dovat, Sinisa (Recipient), Behura, Chandrika (Recipient), Acharya, Jayant (Recipient) & Murray, Michael (Recipient), 2022
Prize